EMEA-002685-PIP02-19-M01
Key facts
Invented name |
Vumerity
|
Active substance |
Diroximel fumarate (BIIB098)
|
Therapeutic area |
Neurology
|
Decision number |
P/0413/2022
|
PIP number |
EMEA-002685-PIP02-19-M01
|
Pharmaceutical form(s) |
Gastro-resistant capsule, hard
|
Condition(s) / indication(s) |
Treatment of multiple sclerosis
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Biogen Netherlands B.V.
E-mail: pip.enquiries@biogen.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|